Type 1 Diabetes

Diabetic ketoacidosis (DKA) continues to be one of the most dangerous acute complications faced by people with diabetes, particularly those on insulin or SGLT2 inhibitors. While traditional approaches rely on intermittent blood ketone checks, a new frontier is emerging—continuous ketone monitoring for DKA prevention. This article explores how this technology …

AI decision support in diabetes care is reshaping how clinicians manage continuous glucose monitoring (CGM) and insulin dosing. These tools deliver quick data-driven recommendations, raising key questions: How do we preserve clinical judgment? Where does AI end and provider expertise begin? This article explains how to safely evaluate and use …

With diabetes technology evolving rapidly, clinicians face more choices than ever before. From continuous glucose monitors (CGMs) to insulin pumps and patch devices, today’s tools can transform diabetes care—but only when matched to the right patient. This article provides a comprehensive diabetes technology comparison, helping you understand each option’s features, …

Type 1 diabetes doesn’t have to be a surprise. Thanks to type 1 diabetes autoantibody screening, clinicians can now identify individuals at high risk before symptoms even appear. This early detection opens doors for proactive monitoring, patient education, and potentially delaying or preventing full-blown disease. But who should be screened? …

Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are still two of the most dangerous acute complications facing people with diabetes. However, a large portion of these cases can be prevented outside of the hospital. In 2025, the American Diabetes Association (ADA) released expanded guidance focused on DKA outpatient prevention, …

As diabetes technology evolves at lightning speed, clinics are under increasing pressure to evaluate a growing range of tools—from continuous glucose monitors (CGMs) and insulin pumps to smartphone apps and cloud platforms. But how can healthcare providers make safe, informed decisions about which tools to recommend? A clear, structured diabetes …

Diabetes technology safety has become a critical focus as continuous glucose monitors (CGMs), insulin pumps, and automated insulin delivery systems transform diabetes care. These tools improve glycemic outcomes, enhance quality of life, and support proactive management. However, with increased device complexity comes a unique set of risks clinicians must recognize …

When a child is diagnosed with diabetes, the clinical response extends beyond prescriptions and in-office education. Managing this chronic condition in school settings presents unique challenges and opportunities. For clinicians, understanding how to support diabetes management at school is essential—not only to safeguard the student’s health, but to empower families …

Telemedicine for diabetes management has transformed the landscape of chronic care. As healthcare systems integrate digital solutions beyond the pandemic, one thing is clear: virtual visits are here to stay. But making telehealth work for diabetes requires more than video calls—it demands structure, thoughtful planning, and patient-centered design. This article …

Diabetes distress and burnout are common but often overlooked challenges affecting people with diabetes. These emotional burdens can negatively influence self‑management, medication adherence, and glycemic control. In routine clinical visits, especially those limited to 15 minutes, clinicians may struggle to address emotional and psychological concerns alongside medical management. However, integrating …